Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Stein, Kvaløy"'
Autor:
Knut B. Smeland, Cecilie E. Kiserud, Grete F. Lauritzsen, Unn-Merete Fagerli, Ragnhild S. Falk, Øystein Fluge, Alexander Fosså, Arne Kolstad, Jon H. Loge, Martin Maisenhölder, Stein Kvaløy, Harald Holte
Publikováno v:
Haematologica, Vol 100, Iss 6 (2015)
Externí odkaz:
https://doaj.org/article/6b95287b85cb42f3aca11dedfe2c1cf4
Autor:
Dag Torfoss, Harald Holte, Sigbjørn Smeland, Sunniva Fagerås Røst, Eldbjørg Vorkinn, Stein Kvaløy
Publikováno v:
Tidsskrift for Den norske legeforening.
Autor:
Klaus Murbraech, Cecilie E. Kiserud, Harald Holte, Stein Kvaløy, Jo S Stenehjem, Torgeir Wethal, May Brit Samersaw-Lund, Knut B. Smeland
Publikováno v:
Acta Oncologica. 57:773-781
Background: Obstructive and restrictive dysfunction in long-term lymphoma survivors (LSs) after high-dose therapy with autologous stem-cell transplantation (HDT-ASCT) has not been addressed systematically previously. Material and methods: LSs treated
Autor:
Harald Holte, Stein Kvaløy, Knut B. Smeland, Cecilie E. Kiserud, Svend Aakhus, Lee W. Jones, Ingerid Arbo, Klaus Murbraech, Lene Thorsen, May Brit Lund, Jo S Stenehjem
Publikováno v:
British Journal of Cancer
Background: Cardiorespiratory fitness as measured by peak oxygen consumption (VO2peak) is a strong predictor of longevity and may be compromised by anticancer therapy, inactivity, and smoking. We compared VO2peak among lymphoma survivors (LSs) with r
Autor:
Bjørn Møller, Tor Åge Myklebust, Stein Kvaløy, Vidar Jetne, Linn M. Åsli, Sverre G. Levernes, Tom Børge Johannesen
Background: Palliative radiotherapy (PRT) comprises half of all radiotherapy use and is an effective and important treatment modality for improving quality of life in incurable cancer patients. We have described the use of PRT in Norway and aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5d7d95bdde0cdb94a08ff8428c91042
Autor:
Jon Håvard Loge, May Brit Lund, Stein Kvaløy, Torgeir Wethal, Håvard Dalen, Svend Aakhus, Assami Rösner, Ragnhild Sørum Falk, Cecilie E. Kiserud, Espen Holte, Harald Holte, Knut B. Smeland, Klaus Murbraech
Publikováno v:
Journal of Clinical Oncology. 33:2683-2691
Purpose We aimed to determine the prevalence of left ventricular systolic dysfunction (LVSD), including symptomatic (ie, heart failure [HF]) and asymptomatic LVSD in adult lymphoma survivors (LSs) after autologous hematopoietic stem-cell transplantat
Autor:
Stein Kvaløy, Arne Kolstad, A. K. Blystad, Grete F. Lauritzsen, Alexander Fosså, Harald Holte, Hanne Skjerven Bersvendsen, E. Aurlien
Publikováno v:
Acta Oncologica. 53:680-687
Recommended treatment for lymphoblastic lymphomas, a highly aggressive, relatively rare lymphoma entity predominantly seen in teenagers and young adults, includes acute lymphoblastic leukemia (ALL)-like induction chemotherapy. Whether these patients
Autor:
Jon Håvard Loge, Stein Kvaløy, Arne Kolstad, A. K. Blystad, Bjørn Østenstad, Cecilie E. Kiserud, Alexander Fosså, Knut B. Smeland, Martin Maisenhölder, Unn-Merete Fagerli, Øystein Fluge, Jens Hammerstrøm, Harald Holte, Grete F. Lauritzsen
Publikováno v:
Tidsskrift for Den norske legeforening. 133:1704-1709
Background High-dose therapy with autologous stem cell support (HDT) has been a treatment option for lymphomas in Norway for 25 years. The purpose of the article was to describe the use of the therapy for lymphomas for the country as a whole and by h
Autor:
Cecilie E. Kiserud, Torgeir Wethal, Harald Holte, May-Brith Lund, Klaus Murbraech, Knut B. Smeland, Jo S Stenehjem, Stein Kvaløy
Publikováno v:
Bone marrow transplantation. 52(4)
Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation
Autor:
Stein Kvaløy, L. Sandvik, Peter Meyer, Jens Hammerstrøm, Tove Skjelbakken, A. K. Lehmann, Lorentz Brinch, Yngvar Fløisand, Ernst Arne Høiby, T. Fladhagen, E. Nyquist, Dag Torfoss, Fredrik Schjesvold, Harald Holte, J. Dalgaard
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 23(3)
In Norway, initial treatment of febrile neutropenia (FN) has traditionally been benzylpenicillin plus an aminoglycoside. Internationally, FN is often treated with a broad-spectrum β-lactam antibiotic. We aimed to compare these two regimens in a pros